Steve Kendall
AeroLeads people directory · profile

Steve Kendall Email & Phone Number

Vice President of Business Development at PI Health Sciences
Location: Los Angeles Metropolitan Area, United States, United States 13 work roles 4 schools
2 work emails found @aitbioscience.com 2 phones found area 909 LinkedIn matched
✓ Verified Jun 2026 4 data sources Profile completeness 100%

Contact Signals · 2 work emails · 2 phones

Work email s****@aitbioscience.com
Direct phone (909) ***-****
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
Vice President of Business Development
Location
Los Angeles Metropolitan Area, United States, United States

Who is Steve Kendall? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Steve Kendall is listed as Vice President of Business Development at PI Health Sciences, based in Los Angeles Metropolitan Area, United States, United States. AeroLeads shows a work email signal at aitbioscience.com, phone signal with area code 909, and a matched LinkedIn profile for Steve Kendall.

Steve Kendall previously worked as Senior Vice President, Business Development at Agno Pharma and Vice President of Business Development, North America at Ardena. Steve Kendall holds Ph.D., Biochemistry And Molecular Biology from University Of Maine.

Company email context

Email format at PI Health Sciences

This section adds company-level context without repeating Steve Kendall's masked contact details.

{first_initial}{last}@aitbioscience.com
89% confidence

AeroLeads found 2 current-domain work email signals for Steve Kendall. Compare company email patterns before reaching out.

Profile bio

About Steve Kendall

• MULTI-TALENTED BUSINESS DEVELOPMENT LEADER with significant global experience in business development and marketing within the biopharmaceutical industry. • Possess a deep understanding of Discovery through Clinical Drug Development in human and animal health sectors with expertise in HTS, DMPK, ADME, medicinal chemistry, analytical development, drug substance API and drug product formulation manufacturing services.• Expert in preclinical and clinical evaluation of small molecules, peptides, RNA therapeutics, biologics and nanomedicines in the oncology, immunology, neuronal, diabetes, infectious diseases, respiratory diseases and fibrosis. • Proficiency in presenting technical data and with respect to clinical outcomes.• Effective relationship-based business development approach focused on building and fostering relationships and managing short and long-term client needs.

Listed skills include Sales Management, Sales, Marketing, Business Development, and 32 others.

Current workplace

Steve Kendall's current company

Company context helps verify the profile and gives searchers a useful next step.

PI Health Sciences
Pi Health Sciences
Vice President of Business Development
Los Angeles, CA, US
AeroLeads page
13 roles

Steve Kendall work experience

A career timeline built from the work history available for this profile.

Senior Vice President, Business Development

Current

Bethlehem, Pennsylvania, US

Agno Pharmaceuticals is a leading, global, small molecule Contract Development and Manufacturing Organization (CDMO), catering to the specific needs of the branded pharmaceutical, biotech, generic, and CDMO sectors. Agno Pharmaceuticals is a US-based, end-to-end premier service provider. We specialize in supplying Registered Starting Materials (RSMs).

Jun 2024 - Present

Vice President Of Business Development, North America

Mariakerke, East Flanders, BE

I lead the North American Business Operations for Ardena where we provided integrated pharmaceutical CDMO services. These included API and drug product manufacturing, logistics and (bio)analytical services to biotech and pharmaceutical customers. The emphasis was on pre-clinical through phase 3.

Jan 2023 - Jun 2024

Director Of Business Development

Mariakerke, East Flanders, BE

Oct 2021 - Jun 2024

Director, Business Development

Hamburg, DE

Responsible for Evotec’s discovery and development contract services supporting novel small molecules and biologics' drug development into the clinic. Leveraging my skills and expertise in driving the revenue generation for Evotec to deliver superior science-driven discovery alliances with pharmaceutical and biotechnology companies. This is accomplished.

Dec 2018 - Oct 2021

Director, Head Of North American Business Operations

Newhouse, Scotland, GB

  • Responsible for launching Clyde Biosciences business in the Americas providing their specialized CRO cardiac toxicology screening services. The stem cell-based assay was part of the Comprehensive in Vitro Proarrhythmia.
  • Lead and coordinate US/CAN Business Development/Sales and Customer Support.
  • Developed a marketing and sales plan to understand customer needs to create a penetrate strategyand create business within the American safety pharmacology market to address unmet needs fromhistorical approaches.
  • Worked with the senior management team to build a corporate strategy and implement at a tacticallevel to engage relevant sales channels based on the plan and established sales budget.
  • Create and manage relationships with KOL’s, consultants and industry professional in the cardiacsafety pharmacology space.
  • Promote the scientific approach of the unique technology of Clyde by giving scientific presentations,organizing workshops and negotiating with clients on a scientific basis.
Nov 2017 - Sep 2018

Director Of Business Development

Protea Biosciences
  • Responsible for business development of Protea's mass spectrometry imaging services as well as analytical services for biotherapeutic characterization, small molecules/peptide analysis, proteomics, metabolomics, and.
  • Lead the business development and sales growth of services relating to Protea’s positioning in the mass spec imaging market. Segment markets for both MALDI and LAESI imaging and develop strategies to create or take.
  • Develop the business for the company’s mass spectrometry LC-MS/MS services portfolio with special focus on life sciences, such as metabolomics, proteomics, protein characterization, protein quantitation, peptide.
  • Maintaining and further expanding the business pipeline of qualified opportunities into the DMPK and preclinical market segment.
  • Building and maintaining new and existing client relations.
  • Attending conferences and exhibitions to represent the company by delivering business & scientific presentations.
Mar 2017 - Oct 2017

Director Of Business Development (West Coast)

Indianapolis, Indiana, US

  • Responsible for corporate business development programs to facilitate preclinical research, GLP-Tox and Phase I-III services growth in the western United States. The primary focus was to expand market share in the.
  • Aggressive prospector with a proven track record of launching into new territories and breaking into new accounts by excelling in cold calling. Implemented a strategic approach for identifying prospective customers.
  • Function as a liaison to support all phases of development – from early discovery research through Phase III and post-approval patent extension programs following all FDA guidances for document preparation and control.
  • Small Molecule – knowledge on filing NCE first in human, 505(b)(2) applications, as well as Generic first to file experience.
  • Large Molecule - proteins, peptides, monoclonal antibodies, antibody-drug conjugates (ADC), NCE and Biosimilar, Vaccines development experience.
  • Support sponsors on assay design and development for LC-MS/MS, ADA, NAb and Biomarker analysis for preclinical or clinical programs.
Feb 2016 - Mar 2017

Director Of Sales And Marketing, Americas

Irvine, CA, US

  • Created de novo an integrated sales and marketing program for GeneTex that included sales and marketing strategy development and execution within North and South America. This, for the first time, allowed the company.
  • Hired and managed the US sales & marketing team with 8 direct reports.
  • Developed, directed and measured the execution of strategic annual/long-term marketing plans in order to meet and exceed sales and revenue commitments/goals.
  • Developed the product/business strategy, its pricing and analysis, and performed ongoing business analysis to drive the brand performance.
  • Constructed work plans, established marketing strategy and conducted forecasts, budget management and control, all within set deadlines.
  • Efficiently managed offline and online marketing channels, lead generation, advertising campaigns, sales promotion campaigns, publisher relations and collaborative ventures
May 2012 - Feb 2016

Sales And Strategic Account Management

Durham, North Carolina, US

  • As a Strategic Account Manager, my responsibilities included leading scientific communications in cooperation with Business Development, Market Assessment and Product/Technology Development efforts to define client.
  • Hired and managed global technical sales team to drive worldwide BioFlux sales goals.
  • Identified, expanded, and maintained strategic key accounts within the vascular biology, inflammation and oncology drug and therapeutic development markets.
  • Developed strategic business development approaches based on analysis of cellular based assay development pipelines, individual company profiles, and market networking.
  • Prospecting of new accounts by identifying potential opportunities and interfacing with relevant contacts.
  • In collaboration with company team members, presented company capabilities to potential key accounts with respect to specific assays, drug targets, and disease indications.
Mar 2009 - May 2012

Research Scientist

Burlington, MA, US

  • Responsibilities included the development of product concept innovation that involved the creation of new products and product line extensions centered on human and murine embryonic stem cells and adult neural and.
  • Responsible for the development of stem cell isolation kits, stem cell media, characterization kits and reporter cell line.
  • Published Cellutions Newsletter article 2007 volume 1 “Isolation of Cardiac Stem Cells and their Differentiation into Cardiomyocytes”.
  • Developed business collaborations with academic laboratories to facilitate the isolation of human cardiac stem cells for therapeutic transplantation.
  • Presented a variety of internal seminars to train and educate sales, technical support and product management staff on stem cell departmental products.
  • Spearheaded the creation of a new confocal microscopy core, which required preparing budget justifications and presentations to senior stakeholders. Evaluated microscopy equipment from competitor companies.
Jun 2007 - Dec 2008

Part-Time Faculty

Fullerton, CA, US

  • Responsible for the tutelage of undergraduate students in the biological sciences. Prepared and taught lesson plans. Responsible for grading and troubleshooting problem areas with students. Major Accomplishments:Taught.
  • 2006(Spring term) Intermediate Molecular Biology: BIOL 309
  • 2006(Fall term) Biology of Aging: BIOL 306
  • 2007(Spring term) Advanced Molecular Biology: BIOL 413
  • Invited editor for Molecular Cell Biology, 6th edition Harvey Lodish et al.
Jan 2006 - Jun 2007

Research Fellow-Oncology

Duarte, CA, US

  • Research centered on developing cutting-edge stem cell based therapeutic approaches for breast and glioma cancers. This was accomplished through elucidating the molecular and biochemical contribution of.
  • Oversaw laboratory management to ensure efficient day-to-day activities of junior laboratory members.
  • Invited speaker at Beckman Symposium and California State University at Fullerton.
  • Contributed significant support for my principle investigator’s production and submission of external grants for maintaining laboratory funding
  • Participated in mentoring in the City of Hope Summer Student Research Program and Joint Mentoring Honors Thesis Research Program through City of Hope and Clermont Collages.
Jun 2004 - Jun 2007
4 education records

Steve Kendall education

Ph.D., Biochemistry And Molecular Biology

University Of Maine

Mba, Finance

American Military University

M.Sc., Neuroscience

Western University

B.Sc., Neuroscience

Brock University
FAQ

Frequently asked questions about Steve Kendall

Quick answers generated from the profile data available on this page.

What company does Steve Kendall work for?

Steve Kendall works for PI Health Sciences.

What is Steve Kendall's role at PI Health Sciences?

Steve Kendall is listed as Vice President of Business Development at PI Health Sciences.

What is Steve Kendall's email address?

AeroLeads has found 2 work email signals at @aitbioscience.com for Steve Kendall at PI Health Sciences.

What is Steve Kendall's phone number?

AeroLeads has found 2 phone signal(s) with area code 909 for Steve Kendall at PI Health Sciences.

Where is Steve Kendall based?

Steve Kendall is based in Los Angeles Metropolitan Area, United States, United States while working with PI Health Sciences.

What companies has Steve Kendall worked for?

Steve Kendall has worked for Pi Health Sciences, Agno Pharma, Ardena, Evotec, and Clyde Biosciences.

How can I contact Steve Kendall?

You can use AeroLeads to view verified contact signals for Steve Kendall at PI Health Sciences, including work email, phone, and LinkedIn data when available.

What schools did Steve Kendall attend?

Steve Kendall holds Ph.D., Biochemistry And Molecular Biology from University Of Maine.

What skills is Steve Kendall known for?

Steve Kendall is listed with skills including Sales Management, Sales, Marketing, Business Development, Product Development, Management, Leadership, and Pharmaceutical Industry.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.